Martingale Asset Management L P Lowers Stock Position in Encompass Health Co. (NYSE:EHC)

Martingale Asset Management L P cut its holdings in shares of Encompass Health Co. (NYSE:EHC) by 1.1% during the third quarter, HoldingsChannel.com reports. The fund owned 176,109 shares of the company’s stock after selling 1,925 shares during the quarter. Martingale Asset Management L P’s holdings in Encompass Health were worth $17,019,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. UMB Bank n.a. grew its position in shares of Encompass Health by 387.7% during the third quarter. UMB Bank n.a. now owns 317 shares of the company’s stock worth $31,000 after acquiring an additional 252 shares during the last quarter. V Square Quantitative Management LLC grew its position in shares of Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after acquiring an additional 140 shares during the last quarter. Oakworth Capital Inc. purchased a new position in shares of Encompass Health during the second quarter worth approximately $40,000. Avior Wealth Management LLC purchased a new position in shares of Encompass Health during the third quarter worth approximately $40,000. Finally, Benjamin F. Edwards & Company Inc. grew its position in shares of Encompass Health by 58.9% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock worth $46,000 after acquiring an additional 198 shares during the last quarter. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

EHC has been the topic of a number of analyst reports. KeyCorp lifted their price objective on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. UBS Group lifted their price objective on shares of Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, September 25th. Truist Financial reiterated a “buy” rating and issued a $116.00 price objective (up from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Royal Bank of Canada lifted their price objective on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. Finally, Barclays lifted their price objective on shares of Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Nine investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, Encompass Health presently has a consensus rating of “Buy” and an average price target of $107.11.

Encompass Health Price Performance

Shares of NYSE EHC opened at $102.84 on Friday. The firm has a market capitalization of $10.36 billion, a P/E ratio of 24.84, a PEG ratio of 1.36 and a beta of 0.88. Encompass Health Co. has a one year low of $63.78 and a one year high of $104.55. The company’s fifty day moving average is $97.74 and its two-hundred day moving average is $91.19. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04.

Encompass Health (NYSE:EHC) last issued its earnings results on Monday, October 28th. The company reported $1.03 EPS for the quarter, topping the consensus estimate of $0.94 by $0.09. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The business’s revenue was up 11.9% on a year-over-year basis. During the same period in the previous year, the firm earned $0.86 EPS. Analysts forecast that Encompass Health Co. will post 4.29 EPS for the current fiscal year.

Encompass Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 0.66%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health’s dividend payout ratio (DPR) is presently 16.43%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.